AARD
Aardvark Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.74
−1.06%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-93.4%
Return on equity
-85.8%
Return on assets
-98.0%
Return on invested capital
0.00x
Asset turnover
-$69.4M
Cash from operations
$3.38
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026